Status: Recruiting
Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
The purpose of this study is to evaluate the efficacy and safety of venetoclax combined with azacitidine regimen for newly diagnosed T-ALL patients.
Participants needed: 28
Trial details
Phase: Phase 2Age: 15+Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Soochow UniversityUpdated: Mar 19, 2026Locations: 1
Eligibility criteria
Patients aged ≥ 15. [+4]
Patients who are allergic to the study drug or drugs with similar chemical struc... [+10]